Bank Of America Corp Tarsus Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 243,112 shares of TARS stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243,112
Previous 229,492
5.93%
Holding current value
$12 Million
Previous $8.34 Million
20.8%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TARS
# of Institutions
162Shares Held
42.2MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$169 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$161 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$120 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$111 Million7.48% of portfolio
-
Cowen And Company, LLC2.2MShares$109 Million1.53% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.32B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...